Disposition Kinetics Characterisation

Disposition kinetics characterisation quantifies drug absorption, distribution, metabolism, and excretion determining plasma and tissue concentration profiles. Intravenous administration eliminates absorption variability enabling clearance and volume of distribution determination. Oral bioavailability assessment compares oral and intravenous exposure characterising absorption efficiency. Population pharmacokinetic analysis incorporates heterogeneous patient populations identifying covariate effects.

Regulatory submissions incorporate comprehensive disposition characterisation supporting dosing recommendations. Metabolism pathway identification guides drug-drug interaction assessment. Transporter involvement in absorption and elimination determines renal function correlations. Tissue distribution assessment predicts organ-specific toxicity risk. Emerging physiologically-based pharmacokinetic modelling predicts human dispositions from preclinical data.